Therapeutics Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RACA and buy or sell other stocks, ETFs, and their options commission-free!About RACA
POINT Biopharma Global, Inc. is a radiopharmaceutical company. It engages in the business of building a platform for the clinical development and commercialization of radioligands that fight cancer.
CEOJoe McCann, PhD
CEOJoe McCann, PhD
Employees—
Employees—
HeadquartersIndianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded2020
Founded2020
Employees—
Employees—
RACA Key Statistics
Market cap1.33B
Market cap1.33B
Price-Earnings ratio13.97
Price-Earnings ratio13.97
Dividend yield—
Dividend yield—
Average volume411.37K
Average volume411.37K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$14.35
52 Week high$14.35
52 Week low$6.57
52 Week low$6.57
Stock Snapshot
With a market cap of 1.33B, Therapeutics Acquisition(RACA) trades at $10.27. The stock has a price-to-earnings ratio of 13.97.
On 2025-11-06, Therapeutics Acquisition(RACA) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 411.37K.
Over the past 52 weeks, Therapeutics Acquisition(RACA) stock has traded between a high of $14.35 and a low of $6.57.
Over the past 52 weeks, Therapeutics Acquisition(RACA) stock has traded between a high of $14.35 and a low of $6.57.
People also own
Based on the portfolios of people who own RACA. This list is generated using Robinhood data, and it’s not a recommendation.